Skip to main content

Table 3 Positivity of HPV infection in study participants in northeastern Guangdong Province of China

From: Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China

HPV type

2013(N = 10,081)

2014(N = 12,876)

2015(N = 5773)

P

n

%(95%CI)

n

%(95%CI)

n

%(95%CI)

6

38

0.38 (0.26–0.50)

57

0.44 (0.33–0.56)

54

0.94 (0.69–1.18)

< 0.001

11

45

0.45 (0.32–0.58)

65

0.50 (0.38–0.63)

38

0.66 (0.45–0.87)

0.085

16

401

3.98 (3.60–4.36)

626

4.86 (4.49–5.23)

404

7.00 (6.34–7.66)

< 0.001

18

91

0.90 (0.72–1.09)

136

1.06 (0.88–1.23)

113

1.96 (1.60–2.31)

< 0.001

31

54

0.54 (0.39–0.68)

93

0.72 (0.58–0.87)

80

1.39 (1.08–1.69)

< 0.001

33

94

0.93 (0.74–1.12)

132

1.03 (0.85–1.20)

89

1.54 (1.22–1.86)

0.001

35

6

0.06 (0.01–0.11)

13

0.10 (0.05–0.16)

20

0.35 (0.16–0.50)

< 0.001

39

41

0.41 (0.28–0.53)

115

0.89 (0.73–1.06)

69

1.20 (0.91–1.48)

< 0.001

42

4

0.04 (0.00–0.08)

7

0.05 (0.01–0.09)

18

0.31 (0.17–0.46)

< 0.001

43

0

0.00

3

0.02 (0.00–0.05)

7

0.12 (0.03–0.21)

< 0.001

44

15

0.15 (0.07–0.22)

32

0.25 (0.16–0.33)

29

0.50 (0.32–0.68)

< 0.001

45

22

0.22 (0.13–0.31)

25

0.19 (0.12–0.27)

10

0.17 (0.07–0.28)

0.529

51

10

0.10 (0.04–0.16)

104

0.81 (0.65–0.96)

131

2.27 (1.89–2.65)

< 0.001

52

254

2.52 (2.21–2.83)

388

3.01 (2.72–3.31)

248

4.30 (3.77–4.82)

< 0.001

53

99

0.98 (0.79–1.17)

165

1.28 (1.09–1.48)

103

1.78 (1.44–2.13)

< 0.001

56

14

0.14 (0.07–0.21)

42

0.33 (0.23–0.42)

27

0.47 (0.29–0.64)

< 0.001

58

214

2.12 (1.84–2.40)

359

2.79 (2.50–3.07)

200

3.46 (2.99–3.94)

< 0.001

59

18

0.18 (0.10–0.26)

29

0.23 (0.14–0.31)

18

0.31 (0.17–0.46)

0.096

66

31

0.31 (0.20–0.42)

54

0.42 (0.31–0.53)

59

1.02 (0.76–1.28)

< 0.001

68

89

0.88 (0.70–1.07)

87

0.68 (0.53–0.82)

39

0.68 (0.46–0.89)

0.095

cp8304

76

0.75 (0.59–0.92)

117

0.91 (0.74–1.07)

103

1.78 (1.44–2.12)

< 0.001

6/11

83

0.82 (0.65–1.00)

120

0.93 (0.77–1.10)

89

1.54 (1.22–1.86)

< 0.001

16/18

484

4.80 (4.38–5.22)

755

5.86 (5.46–6.27)

510

8.83 (8.10–9.57)

< 0.001

4vHPV

567

5.625.17–6.07)

875

6.80 (6.36–7.23)

599

10.38 (9.59–11.16)

< 0.001

9vHPV

1123

11.14 (10.53–11.75)

1706

13.25 (12.66–13.84)

1080

18.71 (17.70–19.71)

< 0.001

HR HPV

1106

10.97 (10.36–11.58)

1651

12.82 (12.24–13.40)

964

16.70 (15.74–17.66)

< 0.001

LR HPV

169

1.68 (1.43–1.93)

267

2.07 (1.83–2.32)

216

3.74 (3.25–4.23)

< 0.001

ANY HPV

1433

14.21 (13.54–14.90)

2248

17.46 (16.80–18.11)

1499

25.97 (24.83–27.10)

< 0.001

  1. 4vHPV: 4-valent HPV types including HPV 6, 11, 16, and 18; 9vHPV: 9-valent HPV types including HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58; HR HPV: high risk HPV types including HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, and cp8304; LR HPV: low risk HPV types including HPV 6, 11, 42, 43, and 44. Any HPV: any of the 21 HPV types mentioned above